English
  • Warning: Illegal string offset 'stockName' in Drupal\five_paisa\Controller\StockDetailController->getData() (line 348 of modules/custom/five_paisa/src/Controller/StockDetailController.php).
  • Notice: Uninitialized string offset: 0 in Drupal\five_paisa\Controller\StockDetailController->getData() (line 348 of modules/custom/five_paisa/src/Controller/StockDetailController.php).
  • Warning: Illegal string offset 'NSEcode' in Drupal\five_paisa\Controller\StockDetailController->getData() (line 349 of modules/custom/five_paisa/src/Controller/StockDetailController.php).
  • Notice: Uninitialized string offset: 0 in Drupal\five_paisa\Controller\StockDetailController->getData() (line 349 of modules/custom/five_paisa/src/Controller/StockDetailController.php).
  • Notice: Undefined index: current_date in Drupal\futures_option\Controller\FuturesController->getOptionData() (line 398 of modules/custom/futures_option/src/Controller/FuturesController.php).
  1. Home
  2. Stocks
  3. Sparc Share Price
  • Chart
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs

    • Sun Pharma Advanced Research Company

    Mid Cap
    ₹218.41
    +0.16 (0.07%)
    • Advice
    • Hold
    21 September, 2024 04:31 BSE: 532872 NSE: SPARCISIN: INE232I01014

    Start SIP in Sun Pharma Advanced Research Company

    Start SIP

    Sun Pharma Advanced Research Company Performance

    Day Range

    • Low 218
    • High 222
    ₹ 218

    52 Week Range

    • Low 196
    • High 473
    ₹ 218
    • Open Price220
    • Previous Close218
    • Volume306464

    Sun Pharma Advanced Research Company Share Price

    • Over 1 Month +2.78%
    • Over 3 Month -6.25%
    • Over 6 Month -39.17%
    • Over 1 Year -6.96%

    Sun Pharma Advanced Research Company Key Statistics

    P/E Ratio -18.3
    PEG Ratio
    Market Cap Cr
    Price to Book Ratio 56.4
    EPS -12
    Dividend 0
    Relative Strength Index 42.47
    Money Flow Index 68.27
    MACD Signal 0.04
    Average True Range 7.31
    Sun Pharma Advanced Research Company Financials
    IndicatorJun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 171714212448
    Operating Expenses Qtr Cr 112124116113126137
    Operating Profit Qtr Cr -95-108-103-91-102-90
    Depreciation Qtr Cr 333333
    Interest Qtr Cr 110000
    Tax Qtr Cr 000000
    Net Profit Qtr Cr -97-107-100-86-95-82
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr 105250
    Operating Expenses Annual Cr 479453
    Operating Profit Annual in Cr -404-214
    Depreciation Cr 1212
    Interest Annual Cr 28
    Tax Annual Cr 00
    Net Profit Annual Cr -388-223
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr -429-69
    Cash from Investing Activity Annual Cr 391-548
    Cash from Financing Annual Activity Cr 43617
    Net Cash Flow Annual Cr 4-1
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr 125513
    Fixed Assets Annual Cr 146133
    Total Non Current Assets Annual Cr 240375
    Total Current Assets Annual Cr 246455
    Total Assets Annual Cr 486830
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs 416
    ROE Annual % -311-43
    ROCE Annual % -159-33
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % -495-85
    IndicatorJun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 1717142124
    Operating Expenses Qtr Cr 110122116113126
    Operating Profit Qtr Cr -93-106-103-91-102
    Depreciation Qtr Cr 33333
    Interest Qtr Cr 11000
    Tax Qtr Cr 00000
    Net Profit Qtr Cr -96-106-100-86-95
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr 105250
    Operating Expenses Annual Cr 478453
    Operating Profit Annual in Cr -402-214
    Depreciation Cr 1312
    Interest Annual Cr 28
    Tax Annual Cr 00
    Net Profit Annual Cr -387-223
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr -429-69
    Cash from Investing Activity Annual Cr 392-548
    Cash from Financing Annual Activity Cr 42617
    Net Cash Flow Annual Cr 5-1
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr 126513
    Fixed Assets Annual Cr 151133
    Total Non Current Assets Annual Cr 246375
    Total Current Assets Annual Cr 269455
    Total Assets Annual Cr 515830
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs 416
    ROE Annual % -308-43
    ROCE Annual % -154-33
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % -493-85
    Invest in Sun Pharma Advanced Research Company

    Sun Pharma Advanced Research Company Technicals

    EMA & SMA

    Current Price
    ₹218.41
    +0.16 (0.07%)
    pointer
    • Bullish Moving Average
    • ___
    • 0
    • Bearish Moving Average
    • ___
    • 16
    • 20 Day
    • ₹223.28
    • 50 Day
    • ₹226.66
    • 100 Day
    • ₹240.45
    • 200 Day
    • ₹255.19
    • 20 Day
    • ₹225.44
    • 50 Day
    • ₹223.91
    • 100 Day
    • ₹224.84
    • 200 Day
    • ₹286.82

    Sun Pharma Advanced Research Company Resistance and Support

    PIVOT
    ₹219.33
    Resistance
    First Resistance 221.06
    Second Resistance 223.71
    Third Resistance 225.44
    RSI 42.47
    MFI 68.27
    MACD Single Line 0.04
    MACD -0.82
    Support
    First Support 216.68
    Second Support 214.95
    Third Supoort 212.30

    Sun Pharma Advanced Research Company Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 319,939 17,286,304 54.03
    Week 469,253 24,551,296 52.32
    1 Month 915,425 35,344,549 38.61
    6 Month 1,078,573 57,434,028 53.25

    Sun Pharma Advanced Research Company Result Highlights

    Sun Pharma Advanced Research Company Synopsis

    NSE-Medical-Biomed/Biotech

    Sun Pharma Advanced is involved in the business activities of Research and experimental development on natural sciences and engineering. Company’s Total Operating Revenue is Rs. 75.55 Cr. and Equity Capital is Rs. 32.45 Cr. for the Year ended 31/03/2024. Sun Pharma Advanced Research Company Ltd. is a Public Limited Listed company incorporated on 01/03/2006 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L73100GJ2006PLC047837 and registration number is 047837.
    Market Cap 7,083
    Sales 68
    Shares in Float 11.03
    No of funds 85
    Yield
    Book Value 56.69
    U/D Vol ratio 1.3
    LTDebt / Equity
    Alpha -0.12
    Beta 1.13

    Sun Pharma Advanced Research Company Shareholding Pattern

    Owner NameJun-24Mar-24Dec-23Sep-23
    Promoters 65.67%65.67%65.67%65.67%
    Mutual Funds 0.08%0.25%0.24%0.23%
    Insurance Companies
    Foreign Portfolio Investors 2.64%3.24%3.3%3.67%
    Financial Institutions/ Banks
    Individual Investors 18.91%16.11%16.09%15.9%
    Others 12.7%14.73%14.7%14.53%

    Sun Pharma Advanced Research Company Management

    Name Designation
    Mr. Dilip S Shanghvi Chairman & Non-Exe.Director
    Dr. T Rajamannar Non Executive Director
    Dr. Robert J Spiegel Independent Director
    Mr. Sudhir V Valia Non Executive Director
    Ms. Bhavna Doshi Independent Director
    Dr. Ferzaan Engineer Independent Director
    Ms. Vidhi Shanghvi Non Exe.Non Ind.Director

    Sun Pharma Advanced Research Company Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Sun Pharma Advanced Research Company Corporate Action

    Date Purpose Remarks
    2024-08-05 Quarterly Results
    2024-05-24 Audited Results
    2024-02-05 Quarterly Results
    2023-11-06 Quarterly Results
    2023-08-07 Quarterly Results

    Sun Pharma Advanced Research Company MF Shareholding

    Name Amount(cr)
    Motilal Oswal Nifty 500 Fund Regular Growth 2,019
    Nippon India Nifty Smallcap 250 Index Fund Reg Gr 1,790
    SBI Nifty Smallcap 250 Index Fund Regular Growth 1,087
    Motilal Oswal Nifty Smallcap 250 Index Fund Regular Growth 822

    Sun Pharma Advanced Research Company FAQs

    What is Share Price of Sun Pharma Advanced Research Company ?

    Sun Pharma Advanced Research Company share price is ₹218 As on 21 September, 2024 | 04:17

    What is the Market Cap of Sun Pharma Advanced Research Company ?

    The Market Cap of Sun Pharma Advanced Research Company is ₹7087.9 Cr As on 21 September, 2024 | 04:17

    What is the P/E ratio of Sun Pharma Advanced Research Company ?

    The P/E ratio of Sun Pharma Advanced Research Company is -18.3 As on 21 September, 2024 | 04:17

    What is the PB ratio of Sun Pharma Advanced Research Company ?

    The PB ratio of Sun Pharma Advanced Research Company is 56.4 As on 21 September, 2024 | 04:17

    Q2FY23
    Open Free Demat Account

    Be a part of 5paisa community - The first listed discount broker of India.

    +91
     

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

    Email: support@5paisa.com

    Support Desk Helpline: 8976689766

    ©2024, 5Paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.